Symbol
| BCL11B
| contributors: mct/shn - updated : 12-09-2017
|
HGNC name
| B-cell CLL/lymphoma 11B (zinc finger protein)
|
HGNC id
| 13222
|
corresponding disease(s)
|
IMD49
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
| translocation
|  
|  
|
translocated with TLX3 in t(5,14)(q35;q32.2) in B cell acute lymphoblastic leukemia | tumoral
|  
| translocation
|  
|  
|
t(2;14)(q34;q32) (fusion of BCL11B and IKZF2) in adult T-cell leukemia/lymphoma (ATLL) | tumoral
|  
|  
| --low
|  
|
is a key event in the multistep progression of ATLL (adult T-cell leukemia/lymphoma) leukemogenesis | |
Variant & Polymorphism
|
| |
Candidate gene
| may be considered a new candidate for targeted gene therapy in T-cell malignancies |
Marker
Therapy target
| | |
| profound apoptosis in the thymus of neonatal Bcl11b-/- mice and adult mice show a block at the CD4-CD8- double-negative stage of thymocyte development |